Orion Biotech Opportunities Overview
Valuation check: ORIA's ROE is 2515104.48%, above the sector sector average of 11.73%.
Get informed when a big investor buys or sells
+ Follow2515104.48%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, ORIA shows a ROE of 2515104.48%. That is above the sector sector average of 11.73%. Scroll down for historical charts and peer comparison views.
The its sector sector average ROE is about 11.73%. Orion Biotech Opportunities is at 2515104.48%, which is higher that average. That is roughly 21434500.9% above the sector mean. Use the comparison chart on this page to see how ORIA stacks up against individual peers as well.
Check the historical chart to see whether ORIA's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Orion Biotech Opportunities with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has Orion Biotech Opportunities's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 2515104.48%) with ownership activity and broader fundamentals.
